The Dual RAF/MEK Inhibitor CH5126766/RO5126766 May Be a Potential Therapy for RAS-Mutated Tumor Cells

Makoto Wada(Kyoto first Red Cross hospital), Toshiyuki Sakai(Kyoto Prefectural University of Medicine)
PLoS ONE
November 25, 2014
Cited by 48


Related Papers